Modern Pediatrics. Ukraine. (2022). 1(121): 49-54. doi 10.15574/SP.2022.121.49
Buznytska  O. V.
V.N. Karazin Kharkiv National University, Ukraine

For citation: Buznytska OV. (2022). Characteristics of lipid metabolism in adolescents with obesity and signs of metabolic syndrome. Modern Pediatrics. Ukraine. 1(121): 49-54. doi 10.15574/SP.2022.121.49.
Article received: Nov 18, 2021. Accepted for publication: Feb 06, 2022.

One of the most important issues of modern medical science is the metabolic syndrome, the origins of which begin in childhood and adolescence. Diagnostic criterias for metabolic syndrome for children are developed by the International Diabetes Federation (IDF, 2007). It is known that atherogenic dyslipidemia is one of the main and early criteria of the metabolic syndrome and plays an important role in the pathogenesis of the atherosclerotic process and associated cardiovascular diseases. Due to the insufficient amount of information about the nature of dyslipidemia in adolescents and the possibilities for its correction and prevention, the study of this problem is relevant.
Purpose – to study the characteristics of lipid profile in adolescents with obesity and signs of metabolic syndrome.
Materials and methods. We examined 200 obese patients aged 14-18 years, who were divided into two groups: with and without metabolic syndrome according to current recommendations. The control group consisted of 30 adolescents with normal body weight of a similar age. To achieve the goal, all adolescents underwent a comprehensive examination with a focus on the lipid profile of blood using standardized methods in accordance with the IFCC recommendations on a Cormay Multi semi-automatic photometer. The level of β-lipoproteins in blood serum was determined by the turbidimetric method of Burstein M. and Samaille F.
Results. In adolescents with metabolic syndrome, signs of atherogenic dyslipidemia were found, manifested in the form of elevated levels of triglycerides, low and very low density lipoprotein cholesterol, β-lipoproteins, a tendency to decrease high density lipoprotein cholesterol. Reliable correlations were established in the lipid profile of the blood of the examined, and reliable relationships were determined between the indicators of atherogenic dyslipidemia and anthropometric measurements, which indicates an increased risk of lipid metabolic disturbances in individuals with abdominal obesity.
Conclusions. The results will help to focus the attention of practitioners regarding atherogenic dyslipidemia in adolescents with obesity and signs of metabolic syndrome, as well as contribute to early therapeutic intervention and prevention of consequences.
The research was carried out in accordance with the principles of the Helsinki declaration. The study protocol was approved by the Local ethics committee of the participating institution. The informed consent of the patient was obtained for conducting the studies.
No conflict of interests was declared by the author.
Key words: adolescents, metabolic syndrome, dyslipidemia.

REFERENCES

1. Barclay L, Desiree L. (2010). Waist-to-height ratio may predict cardiometabolic risk in normal-weiht children CME BMC Pediatr. 10: 73-78.

2. Buznytska OV, Strashok LA. (2021). Сharacteristics of nutrition and content of certain microelements in blood in adolescents with signs of metabolic syndrome. Modern pediatrics. Ukraine. 6 (118): 38-43. https://doi.org/10.15574/SP.2021.118.38

3. Chalasani N, Younossi Z, Lavine JE et al. (2012). The diagnosis and management of non-alcoholic fatty liver disease. Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol. 107 (6): 811-826. https://doi.org/10.1038/ajg.2012.128; PMid:22641309

4. Dania Al-Hamad, Raman V. (2017). Metabolic syndrome in children and adolescents. Translational Pediatrics. 6 (4): 397-407. https://doi.org/10.21037/tp.2017.10.02; PMid:29184820 PMCid:PMC5682379

5. Della Corte C, Alisi A, Saccari A et al. (2015). Nonalcoholic fatty liver in children and adolescents: an overview. J Adolesc Health. 51 (4): 305-312. https://doi.org/10.1016/j.jadohealth.2012.01.010; PMid:22999829

6. Eckel RH, Kahn R, Robertson RA, Rizza RA. (2006). ADA/AHA Scientific Statement. Preventing cardiovascular disease and diabetes: a call for action from the American Diabetes Association and the American Heart Association. Circulation. 113: 2943-2946. https://doi.org/10.1161/CIRCULATIONAHA.106.176583; PMid:16801475

7. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. (2001). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 285: 2486-2497. https://doi.org/10.1001/jama.285.19.2486; PMid:11368702

8. Fang Y, Ma Y, Mo D et al. (2019). Methodology of an exercise intervention program using social incentives and gamification for obese children. BMC Public Health. 19 (1): 686. https://doi.org/10.1186/s12889-019-6992-x; PMid:31159776 PMCid:PMC6547593

9. Fredrickson DS. (1971). An international classification of hyperlipidemias and hyperlipoproteinemias. Ann Intern Med. 75 (3): 471-472. https://doi.org/10.7326/0003-4819-75-3-471; PMid:5568160

10. Gromnatska N, Cherkas A, Lemishko B, Kulya O. (2019). The pattern of metabolic syndrome in children with abdominal obesity. Georgian Med News. 289: 68-72.

11. Heinonen OP, Huttunen JK, Manninen V. (1994). The Helsinki Heart Study: coronary heart disease incidence during an extended follow-up. J of Internal Medicine. 235 (1): 41-49. https://doi.org/10.1111/j.1365-2796.1994.tb01030.x; PMid:8283158

12. Jellinger PS, Smith DA, Mehta AE et al. (2012). American Association of Clinical Endocrinologist' Guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocrine Practice. 18 (1): 78-100. https://doi.org/10.4158/EP.18.S1.1; PMid:22522068

13. Kawada T. (2019). Socioeconomic status and childhood metabolic syndrome. Int J Cardiol. 283: 189. https://doi.org/10.1016/j.ijcard.2019.01.106; PMid:30890248

14. Mantovania А, Zazab G, Byrne CD. (2018). Nonalcoholic fatty liver disease: A systematic review and meta-analysis. Metabolism. 79: 64-76. https://doi.org/10.1016/j.metabol.2017.11.003; PMid:29137912

15. McKrindle BW. (2007). Summary of the American Heart Association's scientific statement on drug Therapy of High – Risk Lipid abnormalities in children and adolescents. Arterioscler Thromb Vasc Biol. 27: 982-985. https://doi.org/10.1161/ATVBAHA.107.143644; PMid:17442893

16. O'Neill S, O'Driscoll L. (2015). Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obesity Reviews. 16 (1): 1-12. https://doi.org/10.1111/obr.12229; PMid:25407540

17. Seo SH, Shim YS. (2019). Association of Sleep Duration with Obesity and Cardiometabolic Risk Factors in Children and Adolescents: A Population-Based Study Sci Rep. 9 (1): 9463. https://doi.org/10.1038/s41598-019-45951-0; PMid:31263172 PMCid:PMC6603036

18. Spreghini N, Cianfarani S, Spreghini MR et al. (2019). Oral glucose effectiveness and metabolic risk in obese children and adolescents. Acta Diabetol. 56 (8): 955-962. https://doi.org/10.1007/s00592-019-01303-y; PMid:30868315

19. Strashok LA, Buznytska OV, Meshkova OM. (2021). Nutrition peculiarities of Ukrainian adolescents with metabolic syndrome. Wiadomosci Lekarskie. 3 (1): 492-498. https://doi.org/10.36740/WLek202103120; PMid:33813456

20. Strashok LA, Buznytska OV. (2021). Anthropometric characteristics of adolescents with signs of metabolic syndrome Modern pediatrics. Ukraine. 5 (117): 35-40. https://doi.org/10.15574/SP.2021.117.35

21. Tagi VM, Giannini C, Chiarelli F. (2019). Insulin Resistance in Children. Front Endocrinol (Lausanne). 10: 342. https://doi.org/10.3389/fendo.2019.00342; PMid:31214120 PMCid:PMC6558106

22. Troisi J, Belmonte F, Bisogno A et al. (2019). Salivary markers of hepato-metabolic comorbidities in pediatric obesity. Dig Liver Dis. 51 (4): 516-523. https://doi.org/10.1016/j.dld.2018.11.009; PMid:30528710

23. Younossi ZM, Loomba R, Anstee QM, Rinella ME, Bugianesi E, Marchesini G. (2018). Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis. Hepatology. 68 (1): 349-360. https://doi.org/10.1002/hep.29721; PMid:29222917 PMCid:PMC6511364

24. Zimmet P, Alberti KG, Kaufman FT et al. (2007). IDF Consensus. The metabolic syndrome in children and adolescents – an IDF consensus report. Pediat Diabetes. 5: 299-306. https://doi.org/10.1111/j.1399-5448.2007.00271.x; PMid:17850473